In a significant step toward strengthening healthcare infrastructure and patient safety, SLB, through its Corporate Social Responsibility (CSR) initiative, has partnered with Ruby Hall Clinic to upgrade the hospital’s blood center facilities. This collaboration that took place on 9th March 2026 aims to enhance transfusion safety, particularly for vulnerable patient groups such as newborns, cancer patients, and organ transplant recipients.
A key highlight of this initiative is the installation of the advanced BI-2000 Blood Irradiator, a critical medical device that plays a vital role in ensuring safe blood transfusions. The technology works by inactivating specific donor white blood cells, thereby preventing Graft-versus-Host Disease (GVHD)—a rare but potentially fatal complication in immunocompromised patients. This upgrade marks a major advancement in delivering safer and more reliable blood products.
Beyond equipment support, SLB has committed to a three-year partnership with Ruby Hall Clinic, which includes ongoing support for the blood center as well as organizing employee-led blood donation drives throughout the year. This initiative is expected to contribute significantly to maintaining an adequate and safe blood supply for the community.
Dr. P.K. Grant, Chief Cardiologist, Chairman and Managing Trustee at Ruby Hall Clinic, shared, “SLB's remarkable support enables us to deliver the safest blood products available. This investment reinforces our dedication to protecting our most vulnerable patients and makes a profound, long-term impact on our community.”
Mr. Abuzar Manager, Global Head and IT Centers Director, SLB, noted, “stated, “At the core, SLB is always a people’s first organization driven by innovative initiatives that foster sustainable and lasting change. Supporting Ruby Hall’s enhanced blood center reflects our commitment and values for providing world-class solutions and working on building a safe and balanced planet for everyone”.
